Intralesional Methotrexate for the Treatment of Keratoacanthoma: The Neapolitan Experience

13Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Introduction: Keratoacanthomas are cutaneous neoplasms known for their rapid growth and spontaneous regression over a long time period. Their treatment can be difficult because of the potentially large field size and number of lesions. Intralesional methotrexate constitutes an effective, nonsurgical treatment of keratoacanthomas, as proven by our experience. Methods: We treated 11 elderly patients affected by keratoacanthoma with intralesional methotrexate. The injections were performed weekly, followed by 10 mg of folic acid to be taken 24 h later. Results: All our patients underwent complete resolution of the lesions after 4–8 injections, without side effects. Conclusion: Intralesional methotrexate seems to be an effective and safe nonoperative treatment modality for keratoacanthoma, especially when it arises in anatomic areas difficult to treat with surgery, in elderly debilitated patients, and in those refusing surgery.

Cite

CITATION STYLE

APA

Scalvenzi, M., Patrì, A., Costa, C., Megna, M., Napolitano, M., Fabbrocini, G., & Balato, N. (2019). Intralesional Methotrexate for the Treatment of Keratoacanthoma: The Neapolitan Experience. Dermatology and Therapy, 9(2), 369–372. https://doi.org/10.1007/s13555-019-0286-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free